| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b7f64f380c538d4b6aa024f05455da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661c68977a99ccd5a68ea29d1b870a1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e96a7912a4e01334aca3ffd3babe863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25a7031cde5cefa9e3c756d0bedc2001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_402e17b93864b223544273eef4003cb3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
| filingDate |
2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e11ce8e072aa26b836d1e38842c2f514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f485298ff55cef6bfb50c90d661049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edfe9e27ad7c379bce32e952a6783670
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab0fa43e2d7cb1c51a8ea86dac758a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94bf899265ebd94190c418ad724c07c9 |
| publicationDate |
2016-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016069510-A1 |
| titleOfInvention |
Piperidine oxadiazole and thiadiazole orexin receptor antagonists |
| abstract |
The present invention is directed to piperidine oxadiazole and thiadiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000499-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10155750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10150751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10227336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11751565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10214535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9994570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10435398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021144566-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10017504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10011595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010539-B2 |
| priorityDate |
2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |